Innovita Biological Technology Co., Ltd.

XSSC:688253 Stock Report

Market Cap: CN¥6.0b

Innovita Biological Technology Past Earnings Performance

Past criteria checks 5/6

Innovita Biological Technology has been growing earnings at an average annual rate of 2.9%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 60.7% per year. Innovita Biological Technology's return on equity is 15.2%, and it has net margins of 44.8%.

Key information

2.9%

Earnings growth rate

-13.2%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate60.7%
Return on equity15.2%
Net Margin44.8%
Next Earnings Update26 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Innovita Biological Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSSC:688253 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2467630313475
31 Mar 2462526613465
31 Dec 2347817410453
30 Sep 2348714910762
30 Jun 2342012010261
31 Mar 2351217810171
31 Dec 224471519772
30 Sep 223731438657
30 Jun 223601337949
31 Mar 22267788136
31 Dec 213271208431
31 Dec 201,03757115359
31 Dec 19138216621
31 Dec 1879173411

Quality Earnings: 688253 has high quality earnings.

Growing Profit Margin: 688253's current net profit margins (44.8%) are higher than last year (28.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688253's earnings have grown by 2.9% per year over the past 5 years.

Accelerating Growth: 688253's earnings growth over the past year (153.3%) exceeds its 5-year average (2.9% per year).

Earnings vs Industry: 688253 earnings growth over the past year (153.3%) exceeded the Medical Equipment industry -8.6%.


Return on Equity

High ROE: 688253's Return on Equity (15.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies